Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:14 pm Purchase | 2021-12-31 | 13G | IMMATICS N V IMTX | BAKER BROS. ADVISORS LP | 4,423,731 7.000% | 4,423,731 (New Position) | Filing History |
| 2022-02-14 4:14 pm Purchase | 2021-12-31 | 13G | GLOBAL BLOOD THERAPEUTICS INC GBT | BAKER BROS. ADVISORS LP | 3,314,765 5.100% | 3,314,765 (New Position) | Filing History |
| 2022-02-14 4:14 pm Purchase | 2021-12-31 | 13G | AEROVATE THERAPEUTICS INC AVTE | BAKER BROS. ADVISORS LP | 52,337 7.500% | 52,337 (New Position) | Filing History |
| 2022-02-14 4:13 pm Purchase | 2021-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | BAKER BROS. ADVISORS LP | 4,541,604 8.000% | 1,001,334 (+28.28%) | Filing History |
| 2022-02-14 4:13 pm Sale | 2021-12-31 | 13G | AMARIN CORP PLC SPONSORED ADR AMRN | BAKER BROS. ADVISORS LP | 1,064,659 5.400% | -341,098 (-24.26%) | Filing History |
| 2022-02-14 4:13 pm Purchase | 2021-12-31 | 13G | ALTIMMUNE INC ALT | BAKER BROS. ADVISORS LP | 1,941,604 4.800% | 57,153 (+3.03%) | Filing History |
| 2022-02-14 4:13 pm Purchase | 2021-12-31 | 13G | ALIGOS THERAPEUTICS INC ALGS | BAKER BROS. ADVISORS LP | 83,056 5.300% | 83,056 (New Position) | Filing History |
| 2022-02-14 4:12 pm Purchase | 2021-12-31 | 13G | ACHILLES THERAPEUTICS PLC ACHL | BAKER BROS. ADVISORS LP | 4,039,480 9.990% | 4,039,480 (New Position) | Filing History |
| 2022-02-10 5:03 pm Purchase | 2022-02-09 | 13D | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | BAKER BROS. ADVISORS LP | 201,779 9.900% | 5,731 (+2.92%) | Filing History |
| 2022-01-31 5:10 pm Purchase | 2022-01-27 | 13D | KODIAK SCIENCES INC KOD | BAKER BROS. ADVISORS LP | 15,566,068 30.100% | 848,776 (+5.77%) | Filing History |
| 2021-12-16 5:23 pm Unchanged | 2021-12-14 | 13D | ENTRADA THERAPEUTICS INC TRDA | BAKER BROS. ADVISORS LP | 4,704,419 15.100% | 0 (Unchanged) | Filing History |
| 2021-11-10 4:50 pm Purchase | 2021-11-02 | 13G | ENTRADA THERAPEUTICS INC TRDA | BAKER BROS. ADVISORS LP | 4,704,419 15.100% | 4,704,419 (New Position) | Filing History |
| 2021-10-01 5:10 pm Purchase | 2021-09-29 | 13D | KODIAK SCIENCES INC KOD | BAKER BROS. ADVISORS LP | 14,717,292 28.500% | 393,424 (+2.75%) | Filing History |
| 2021-07-26 5:21 pm Purchase | 2021-07-22 | 13D | KODIAK SCIENCES INC KOD | BAKER BROS. ADVISORS LP | 14,323,868 27.800% | 269,170 (+1.92%) | Filing History |
| 2021-07-22 4:20 pm Purchase | 2021-07-20 | 13D | TSCAN THERAPEUTICS INC TCRX | BAKER BROS. ADVISORS LP | 1,425,000 7.600% | 1,425,000 (New Position) | Filing History |
| 2021-05-20 5:25 pm Unchanged | 2021-05-10 | 13D | IMMUNOCORE HLDGS PLC ADS IMCR | BAKER BROS. ADVISORS LP | 3,352,357 7.700% | 0 (Unchanged) | Filing History |
| 2021-05-18 4:42 pm Sale | 2021-05-14 | 13D | INCYTE CORPORATION INCY | BAKER BROS. ADVISORS LP | 32,524,420 14.800% | -57,539 (-0.18%) | Filing History |
| 2021-05-18 4:41 pm Purchase | 2021-05-14 | 13D | SEATTLE GENETICS INC SGEN | BAKER BROS. ADVISORS LP | 47,618,503 26.200% | 3,226 (+0.01%) | Filing History |
| 2021-05-10 5:08 pm Purchase | 2021-04-30 | 13G | VERASTEM, INC. VSTM | BAKER BROS. ADVISORS LP | 1,557,141 10.900% | 711,804 (+84.20%) | Filing History |
| 2021-04-12 5:05 pm Purchase | 2021-03-31 | 13G | OTONOMY INC OTIC | BAKER BROS. ADVISORS LP | 7,220,074 14.900% | 7,220,074 (New Position) | Filing History |